Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Sep 30;10(11):2124–2132. doi: 10.1111/1759-7714.13196

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd

This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

High PHLPP2 expression correlated with favorable survival outcomes in NSCLC patients. (a) Kaplan‐Meier analysis of overall (left) and disease‐free survival (right) for high and low PHLPP2 expression levels. () Low‐PHLPP2 and () high‐PHLPP2. (b) Kaplan‐Meier survival curves of OS and PPS comparing high and low PHLPP2 expression estimates of NSCLC patient survival probability determined from the Kaplan‐Meier plotter database (213407_at). Expression () low and () high. * P < 0.05 was considered statistically significant.

Inline graphic — High PHLPP2 expression correlated with favorable survival outcomes in NSCLC patients. (a) Kaplan‐Meier analysis of overall (left) and disease‐free survival (right) for high and low PHLPP2 expression levels. () Low‐PHLPP2 and () high‐PHLPP2. (b) Kaplan‐Meier survival curves of OS and PPS comparing high and low PHLPP2 expression estimates of NSCLC patient survival probability determined from the Kaplan‐Meier plotter database (213407_at). Expression () low and () high. * P < 0.05 was considered statistically significant.